Skip to main content
Premium Trial:

Request an Annual Quote

SAS, Affymetrix, Illumina, Asper Biotech, University of Zurich

SAS this week launched JMP Genomics 3.1, a genomics analysis software package that offers users the ability to analyze copy number variation, SNP, and proteomics data sets.
Specifically, JMP Genomics 3.1 offers copy number import tools for common formats, including Affymetrix and Illumina output files; copy number analysis tools for large SNP intensity data sets; Affymetrix CHP Expression Wizard; NetAffx download capabilities; principal components analysis for population stratification; interactive Venn diagrams; and expanded documentation of individual features.
SAS said it offers department, campus-wide, and core-lab licensing options for academic groups to use for teaching and research. Prospective users can license JMP Genomics or request a free 30-day trial of the software.

Asper Biotech this month launched a chip for screening mutations associated with congenital stationary night blindness, an inherited eye disorder.
The test has been developed for screening mutations of three forms of CSNB — autosomal dominant, autosomal recessive, and X-linked — and can be used for screening 127 mutations in 9 genes: RHO, PDE6B, GNAT1, CABP4, GRM6, SAG, NYX, CACNA1F and CACNA2D.
The chip was developed with the Institute of Medial Genetics at the University of Zurich.
Asper also said that it has updated its AD-RP Chip, which analyzes 12 new mutations associated with autosomal dominant retinitis pigmentosa. Currently the test can be used to screen 353 mutations in 13 genes: CA4, FSCN2, IMPDH1, NRL, PRPF3, PRPF31, PRPF8, RDS, RHO, ROM1, RP1, RP9 and CRX.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.